FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

7 results

alendronate
(ALENDRONATE SODIUM)
Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
Usage: Alendronate sodium tablets are indicated for treating and preventing osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, treating glucocorticoid-induced osteoporosis, and treating Paget’s disease of bone. Use should be periodically re-evaluated, particularly for low-risk fracture patients after 3 to 5 years.
alendronate
(Alendronate sodium tablet)
Marlex Pharmaceuticals Inc
Usage: Alendronate sodium is indicated for treating osteoporosis in postmenopausal women, increasing bone mass in men with osteoporosis, preventing postmenopausal osteoporosis, treating glucocorticoid-induced osteoporosis, and managing Paget's disease of bone in symptomatic patients or those at risk for complications. Reinforcement of therapy need is recommended periodically.
estradiol
(Estradiol)
Teva Pharmaceuticals USA, Inc.
Usage: Estradiol tablets are indicated for treating moderate to severe menopause symptoms, vulvar and vaginal atrophy, hypoestrogenism, and for palliation in breast cancer and prostate cancer. They may also be used for preventing osteoporosis in postmenopausal women at significant risk when non-estrogen options are unsuitable.
forteo
(Teriparatide)
Eli Lilly and Company
Usage: FORTEO is indicated for treating high-risk postmenopausal women and men with osteoporosis, including those intolerant to other therapies. It also increases bone mass in men with primary or hypogonadal osteoporosis and treats osteoporosis related to long-term glucocorticoid use, reducing fracture risk in these populations.
risedronate sodium
(Risedronate Sodium)
Teva Pharmaceuticals USA, Inc.
Usage: Risedronate sodium tablets are indicated for the treatment and prevention of postmenopausal osteoporosis, osteoporosis in men, glucocorticoid-induced osteoporosis, and Paget’s disease of bone. Regular evaluation of therapy necessity and fracture risk is recommended for long-term users.
teriparatide
(Teriparatide)
Prasco Laboratories
Usage: Teriparatide Injection is indicated for treating postmenopausal women and men with osteoporosis at high fracture risk, including those intolerant to other therapies. It also treats osteoporosis in individuals on long-term glucocorticoid therapy, reducing the risk of vertebral and nonvertebral fractures.
tymlos
(abaloparatide)
Radius Health, Inc.
Usage: TYMLOS is indicated for treating postmenopausal women and men with osteoporosis at high fracture risk, including those with previous osteoporotic fractures or multiple risk factors. It is suitable for patients intolerant to or who have failed other osteoporosis therapies, aiming to reduce fracture risk and increase bone density.

Medications for Osteoporosis

alendronate

alendronate

estradiol

forteo

risedronate sodium

teriparatide

tymlos